March 2, 2020 / 9:44 PM / a month ago

BRIEF-Sandoz Resolves Generic Drug Antitrust Investigation In U.S.

March 2 (Reuters) -

* SANDOZ RESOLVES GENERIC DRUG ANTITRUST INVESTIGATION IN THE U.S.

* SANDOZ INC SAYS AGREED TO PAY $195 MILLION AND WILL ENTER INTO A DEFERRED PROSECUTION AGREEMENT IN U.S.

* SANDOZ INC -CO ALSO IN SETTLEMENT NEGOTIATIONS WITH DOJ CIVIL DIVISION TO RESOLVE POTENTIAL RELATED CLAIMS ; CO TAKING PROVISION OF $185 MILLION FOR IT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below